Acute Myelogenous Leukemia (AML)
What is acute myelogenous leukemia (AML)?
Acute myelogenous leukemia (AML) is a cancer of the blood and bone marrow — the spongy tissue inside bones where blood cells are made. In AML, the bone marrow makes abnormal myeloblasts (a type of white blood cell), red blood cells, or platelets. These abnormal cells crowd out the healthy blood cells, making it hard for blood to do its work.What are the symptoms of acute myelogenous leukemia (AML)?
The symptoms of AML include the following:- Fever
- Bone pain
- Lethargy and fatigue
- Shortness of breath
- Pale skin
- Frequent infections
- Easy bruising
- Unusual bleeding, such as frequent nosebleeds and bleeding from the gums
What causes acute myelogenous leukemia (AML)?
AML is caused by damage to the DNA of developing cells in the bone marrow. The bone marrow produces immature cells that develop into leukemic white blood cells called myeloblasts. These abnormal cells are unable to function properly, and they can build up and crowd out healthy cells. In most cases, it’s not clear what causes the DNA mutations that lead to leukemia. However – radiation, exposure to certain chemicals, and some chemotherapy drugs are known risks.How is acute myelogenous leukemia (AML) diagnosed?
Diagnostic tests include:- Blood tests
- Bone marrow test
- Lumbar puncture (spinal tap)
What are the treatments for acute myelogenous leukemia (AML)?
AML treatment depends on several factors, including the subtype of the disease, age, overall health, and preferences. In general, treatment falls into two phases:- Remission induction therapy
- Consolidation therapy
- Chemotherapy
- Other drug therapies, like arsenic trioxide (Trisenox) and all-trans retinoic acid (ATRA), which are anti-cancer drugs that can be used alone or in combination with chemotherapy for remission induction of a certain subtype of AML called promyelocytic leukemia. These drugs cause leukemia cells with a specific gene mutation to mature and die, or to stop dividing
- Stem cell transplant
Where can I find out more about acute myelogenous leukemia (AML)?
Acute Myelogenous Leukemia (AML) Articles
Experimental Treatment Could be Useful in Numerous Rare and Deadly Cancers
Rose Duesterwald
January 14, 2021
Read More »
Kura Oncology Announces Clinical Data for KO-539, an AML Treatment
Rose Duesterwald
December 23, 2020
Read More »
Astellas Pharma Provides Help, Guidance, and Hope for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Rose Duesterwald
November 16, 2020
Read More »
This FDA Approved Acute Myeloid Leukemia Drug Got Shut Down in the EU. Why?
James Moore
November 10, 2020
Read More »
A New Investigative Treatment Option for Acute Myeloid Leukemia Produces Positive Results
Trudy Horsting
October 29, 2020
Read More »